[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 3389 Introduced in Senate (IS)]

<DOC>






119th CONGRESS
  1st Session
                                S. 3389

               To lower health care costs for Americans.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                            December 9, 2025

 Mr. Marshall introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL


 
               To lower health care costs for Americans.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

    (a) Short Title.--This Act may be cited as the ``Lowering Health 
Care Costs for Americans Act''.
    (b) Table of Contents.--The table of contents for this Act is as 
follows:

Sec. 1. Short title; table of contents.
                      TITLE I--GENERAL PROVISIONS

Sec. 101. Minimum monthly premium payments.
Sec. 102. Requiring biometric and ID verification.
Sec. 103. Facilitating enrollment in and payment into Healthcare 
                            Affordability Accounts.
Sec. 104. Healthcare Affordability Accounts.
Sec. 105. Extension of temporary enhanced premium credits.
Sec. 106. Special rules relating to coverage of abortion services.
Sec. 107. Special rules relating to credit for plans covering abortion 
                            services.
Sec. 108. Reporting of health insurance coverage.
Sec. 109. Exclusion of gender transition procedures from coverage under 
                            qualified health plans.
Sec. 110. Funding cost sharing reduction payments.
Sec. 111. Waivers for State innovation.
              TITLE II--HOSPITAL TRANSPARENCY REQUIREMENTS

Sec. 201. Strengthening hospital price transparency requirements.
Sec. 202. Increasing price transparency of clinical diagnostic 
                            laboratory tests.
Sec. 203. Imaging transparency.
Sec. 204. Ambulatory surgical center price transparency requirements.
Sec. 205. Strengthening health coverage transparency requirements.
Sec. 206. Increasing group health plan access to health data.
Sec. 207. Oversight of administrative service providers.
Sec. 208. State preemption only in event of conflict.
Sec. 209. Requirement for explanation of benefits.
Sec. 210. Provision of itemized bills.

                      TITLE I--GENERAL PROVISIONS

SEC. 101. MINIMUM MONTHLY PREMIUM PAYMENTS.

    (a) In General.--Section 36B(b) of the Internal Revenue Code of 
1986 is amended by adding at the end the following new paragraph:
            ``(4) Limitation.--Notwithstanding paragraphs (2) and (3), 
        in no case shall the premium assistance amount with respect to 
        any coverage month exceed the excess (if any) of the amount 
        determined under paragraph (2)(A) over--
                    ``(A) in the case of a taxpayer whose household 
                income (expressed as a percent of the poverty line) is 
                less than 200 percent, $10,
                    ``(B) in the case of a taxpayer whose household 
                income (expressed as a percent of the poverty line) is 
                not less than 200 percent, and less than 300 percent, 
                $20,
                    ``(C) in the case of a taxpayer whose household 
                income (expressed as a percent of the poverty line) is 
                not less than 300 percent, and less than 400 percent, 
                $30, and
                    ``(D) in the case of a taxpayer whose household 
                income (expressed as a percent of the poverty line) is 
                not less than 400 percent, $40.''.
    (b) Effective Date.--The amendment made by this section shall apply 
to taxable years beginning after December 31, 2025.

SEC. 102. REQUIRING BIOMETRIC AND ID VERIFICATION.

    Section 1411(b)(1) of Patient Protection and Affordable Care Act 
(42 U.S.C. 18081(b)(1)) is amended--
            (1) in subparagraph (A), by striking ``; and'' and 
        inserting a semicolon;
            (2) by redesignating subparagraph (B) as subparagraph (C); 
        and
            (3) by inserting after subparagraph (A) the following:
                    ``(B) government-issued photo identification for 
                each enrollee over the age of 18, and any other 
                documentation as the Administrator of the Centers for 
                Medicare & Medicaid Services may require for purposes 
                of enrollment verification; and''.

SEC. 103. FACILITATING ENROLLMENT IN AND PAYMENT INTO HEALTHCARE 
              AFFORDABILITY ACCOUNTS.

    (a) In General.--Section 1311 of the Patient Protection and 
Affordable Care Act (42 U.S.C. 18031) is amended--
            (1) in subsection (b)(1)--
                    (A) in subparagraph (B), by striking ``and'' at the 
                end;
                    (B) by redesignating subparagraph (C) as 
                subparagraph (D); and
                    (C) by inserting after subparagraph (B) the 
                following:
                    ``(C) in the case of plan years beginning after 
                December 31, 2026, and before January 1, 2032, 
                facilitates enrollment in Healthcare Affordability 
                Accounts described in section 223(i) of the Internal 
                Revenue Code of 1986, for qualified individuals who 
                purchase qualified health plans and are eligible for 
                premium tax credits under section 36B; and'';
            (2) by adding at the end of subsection (c) the following:
            ``(8) Enrollment in healthcare affordability accounts.--The 
        Secretary shall establish a procedure for notifying qualified 
        individuals who purchase qualified health plans and who are 
        eligible for a premium tax credit under section 36B of the 
        Internal Revenue Code of 1986 of the need to enroll in a 
        Healthcare Affordability Account described in section 223(i) of 
        such Code, in order to receive such credit, for plan years 
        beginning after December 31, 2026, and before January 1, 
        2032.''; and
            (3) in subsection (d)(4)(G), by inserting ``, and, for plan 
        years beginning after December 31, 2026, and before January 1, 
        2032, make available to any individual qualifying for such a 
        tax credit, a link to the application on the website of the 
        Department of the Treasury for enrollment in a Healthcare 
        Affordability Account described in section 223(i) of the 
        Internal Revenue Code of 1986'' before the semicolon at the 
        end.
    (b) Payment of Premium Tax Credits Into Healthcare Affordability 
Accounts.--Section 1412 of the Patient Protection and Affordable Care 
Act (42 U.S.C. 18082) is amended--
            (1) in subsection (a)(3)--
                    (A) by striking ``the Secretary of the Treasury 
                makes advance payments'' and inserting ``the Secretary 
                of the Treasury--
                    ``(A) except as provided in subparagraph (B), makes 
                advance payments'';
                    (B) by striking the period at the end and inserting 
                ``, and''; and
                    (C) by adding at the end the following new 
                subparagraph:
                    ``(B) in the case of a plan year beginning after 
                December 31, 2026, and before January 1, 2032, makes 
                advance payments--
                            ``(i) of such premium tax credit into the 
                        Healthcare Affordability Account maintained 
                        under section 223(i) of the Internal Revenue 
                        Code of 1986 for each individual eligible for 
                        such credit; and
                            ``(ii) of such cost-sharing reductions to 
                        the issuers of the qualified health plans in 
                        order to reduce the premiums payable by 
                        individuals eligible for such cost-sharing 
                        reductions.''; and
            (2) in subsection (c)(2)--
                    (A) by striking ``The Secretary'' and inserting 
                ``Except as provided in subparagraph (C), the 
                Secretary''; and
                    (B) by adding at the end the following new 
                subparagraph:
                    ``(C) Payment of premium tax credit into healthcare 
                affordability accounts.--In the case of plan years 
                beginning after December 31, 2026, and before January 
                1, 2031, the Secretary of the Treasury shall make the 
                advance payment under this section of any premium tax 
                credit allowed under section 36B of the Internal 
                Revenue Code of 1986 to the Healthcare Affordability 
                Account of the applicable individual on a monthly basis 
                (or such other periodic basis as the Secretary may 
                provide).''.

SEC. 104. HEALTHCARE AFFORDABILITY ACCOUNTS.

    (a) In General.--Section 223 of the Internal Revenue Code of 1986 
is amended by adding at the end the following new subsection:
    ``(i) Healthcare Affordability Accounts.--For purposes of this 
section--
            ``(1) In general.--In the case of a Healthcare 
        Affordability Account, this section shall be applied as 
        provided in paragraphs (3) through (7).
            ``(2) Healthcare affordability account.--The term 
        `Healthcare Affordability Account' means a health savings 
        account, determined as provided in this subsection.
            ``(3) Treatment of transferred contributions.--Amounts 
        transferred to a Healthcare Affordability Account pursuant to 
        section 1412 of the Patient Protection and Affordable Care Act 
        shall not be taken into account in determining the deduction 
        allowed by subsection (a).
            ``(4) Account must be only hsa of individual.--
                    ``(A) In general.--An individual who has a 
                Healthcare Affordability Account shall not be treated 
                as an eligible individual with respect to any health 
                savings account other than such Healthcare 
                Affordability Account.
                    ``(B) Rollover of existing account permitted.--An 
                individual on whose behalf a Healthcare Affordability 
                Account is established may roll over the balance of any 
                other health savings account of the individual to such 
                Healthcare Affordability Account according to the rules 
                of subsection (f)(5).
            ``(5) No rollovers permitted.--Except as provided in 
        paragraph (4)(B), subsection (f)(5) shall not apply and no 
        amount shall be contributed from a Healthcare Affordability 
        Account to any health savings account other than a Healthcare 
        Affordability Account.
            ``(6) Restriction on use of amounts.--No amounts in a 
        Healthcare Affordability Account may be used to pay for any--
                    ``(A) gender transition procedures, or
                    ``(B) abortion.
            ``(7) Definitions.--For purposes of paragraph (6)--
                    ``(A) Gender transition procedure.--
                            ``(i) In general.--The term `gender 
                        transition procedure' means any hormonal or 
                        surgical intervention for the purpose of gender 
                        transition, including--
                                    ``(I) gonadotropin-releasing 
                                hormone (GnRH) agonists or other 
                                puberty-blocking or suppressing drugs 
                                to stop or delay normal puberty;
                                    ``(II) testosterone, estrogen, 
                                progesterone, or other androgens to an 
                                individual at doses that are 
                                supraphysiologic to what would normally 
                                be produced endogenously in a healthy 
                                individual of the same age and sex;
                                    ``(III) castration;
                                    ``(IV) orchiectomy;
                                    ``(V) scrotoplasty;
                                    ``(VI) implantation of erection or 
                                testicular prostheses;
                                    ``(VII) vasectomy;
                                    ``(VIII) hysterectomy;
                                    ``(IX) oophorectomy;
                                    ``(X) ovariectomy;
                                    ``(XI) reconstruction of the fixed 
                                part of the urethra with or without a 
                                metoidioplasty or a phalloplasty;
                                    ``(XII) metoidioplasty;
                                    ``(XIII) penectomy;
                                    ``(XIV) phalloplasty;
                                    ``(XV) vaginoplasty;
                                    ``(XVI) clitoroplasty;
                                    ``(XVII) vaginectomy;
                                    ``(XVIII) vulvoplasty;
                                    ``(XIX) reduction 
                                thyrochondroplasty;
                                    ``(XX) chondrolaryngoplasty;
                                    ``(XXI) mastectomy;
                                    ``(XXII) tubal ligation;
                                    ``(XXIII) sterilization;
                                    ``(XXIV) any plastic, cosmetic, or 
                                aesthetic surgery that feminizes or 
                                masculinizes the facial or other 
                                physiological features of an 
                                individual;
                                    ``(XXV) any placement of chest 
                                implants to create feminine breasts;
                                    ``(XXVI) any placement of fat or 
                                artificial implants in the gluteal 
                                region;
                                    ``(XXVII) augmentation mammoplasty;
                                    ``(XXVIII) liposuction;
                                    ``(XXIX) lipofilling;
                                    ``(XXX) voice surgery;
                                    ``(XXXI) hair reconstruction;
                                    ``(XXXII) pectoral implants; and
                                    ``(XXXIII) the removal of any 
                                otherwise healthy or non-diseased body 
                                part or tissue.
                            ``(ii) Exclusions.--The term `gender 
                        transition procedure' does not include the 
                        following when furnished to an individual by a 
                        health care provider with the consent of such 
                        individual or, if applicable, such individual's 
                        parents or legal guardian:
                                    ``(I) Services to individuals born 
                                with a medically verifiable disorder of 
                                sex development, including an 
                                individual with external sex 
                                characteristics that are irresolvably 
                                ambiguous, such as an individual born 
                                with 46 XX chromosomes with 
                                virilization, an individual born with 
                                46 XY chromosomes with 
                                undervirilization, or an individual 
                                born having both ovarian and testicular 
                                tissue.
                                    ``(II) Services provided when a 
                                physician has otherwise diagnosed a 
                                disorder of sexual development in which 
                                the physician has determined through 
                                genetic or biochemical testing that the 
                                individual does not have normal sex 
                                chromosome structure, sex steroid 
                                hormone production, or sex steroid 
                                hormone action for a healthy individual 
                                of the same sex and age.
                                    ``(III) The treatment of any 
                                infection, injury, disease, or disorder 
                                that has been caused by or exacerbated 
                                by the performance of gender transition 
                                procedures, whether or not the gender 
                                transition procedure was performed in 
                                accordance with State and Federal law 
                                or whether or not funding for the 
                                gender transition procedure is 
                                permissible under this section.
                                    ``(IV) Any procedure undertaken 
                                because the individual suffers from a 
                                physical disorder, physical injury, or 
                                physical illness (but not mental, 
                                behavioral, or emotional distress or a 
                                mental, behavioral, or emotional 
                                disorder) that would, as certified by a 
                                physician, place the individual in 
                                imminent danger of death or impairment 
                                of major bodily function, unless the 
                                procedure is performed.
                                    ``(V) Puberty suppression or 
                                blocking prescription drugs for the 
                                purpose of normalizing puberty for a 
                                minor experiencing precocious puberty.
                                    ``(VI) Male circumcision.
                    ``(B) Gender transition.--The term `gender 
                transition' means the process in which an individual 
                goes from identifying with or presenting as his or her 
                sex to identifying with or presenting a self-proclaimed 
                identity that does not correspond with or is different 
                from his or her sex, and may be accompanied with 
                social, legal, or physical changes.
                    ``(C) Sex.--The term `sex', when referring to an 
                individual's sex, means to refer to either male or 
                female, as biologically determined.
                    ``(D) Female.--The term `female', when used to 
                refer to a natural person, means an individual who 
                naturally has, had, will have, or would have, but for a 
                congenital anomaly, histo